Virocure

Developer of naturally occurring oncotropic viruses to treat cancers

placeSeoul, Seoul, South Korea calendar_todayFounded 2016 groups9 employees language virocure.net

Innovation

21 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 622 times.

YearFilings
20171
20193
20206
20213
20227
20235
20246
20253

Investor mix

5 investors on record; lead investors include Wonik Investment Partners, ActnerLab, Supreme Investment Corporation, DT Investment Partners.

Investor typeCountShare
Venture capital240%
Accelerator & incubator120%
Other / undisclosed240%
Coming soon